TD Waterhouse Canada’s BioNTech BNTX Stock Holding History

TD Waterhouse Canada’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.01K	Hold	32	–	–	﹤0.01%	2069
2026 Q1	$2.86K	Hold	32	–	–	﹤0.01%	1999
2025 Q4	$3.04K	Buy	+32	New	+$3.22K	﹤0.01%	1773
2025 Q1	–	Sell	-20	Closed	-$2.28K	–	1963
2024 Q4	$2.28K	Buy	+20	New	+$2.28K	﹤0.01%	1694
2024 Q2	–	Sell	-30	Closed	-$3.72K	–	1923
2024 Q1	$3.72K	Hold	30	–	–	﹤0.01%	1584
2023 Q4	$4.31K	Hold	30	–	–	﹤0.01%	1401
2023 Q3	$3.38K	Hold	30	–	–	﹤0.01%	1428
2023 Q2	$3.24K	Hold	30	–	–	﹤0.01%	1466
2023 Q1	$3.89K	Sell	30 -752	-96%	-$103K	﹤0.01%	1426
2022 Q4	$145K	Buy	782 +727	+1,322%	+$112K	﹤0.01%	692
2022 Q3	$7.52K	Hold	55	–	–	﹤0.01%	1279
2022 Q2	$8.66K	Hold	55	–	–	﹤0.01%	1280
2022 Q1	$11.2K	Buy	+55	New	+$9.24K	﹤0.01%	1303

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

TD Waterhouse Canada's BNTX Position: Q2 2026 in Review

TD Waterhouse Canada held its BioNTech (BNTX) position steady in Q2 2026 at 32 shares worth $3.01K. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

TD Waterhouse Canada first reported a position in BNTX in Q1 2022 and has held it in 13 quarters since. The position peaked at $145K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

TD Waterhouse Canada held 32 shares of BioNTech worth $3.01K as of Q2 2026.
TD Waterhouse Canada left its BioNTech share count unchanged in Q2 2026.
BioNTech made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2069 holding.
TD Waterhouse Canada first reported a position in BioNTech in Q1 2022 and has held it in 13 quarters since.
TD Waterhouse Canada's BioNTech position peaked at $145K in Q4 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.